首页 › 基金 › Parkman Healthcare Partners LLC › RCUS
Parkman Healthcare Partners LLC 对 RCUS 的持仓历史
ARCUS BIOSCIENCES INC · 医疗保健
Parkman Healthcare Partners LLC 在 Q3 2026 的 13F 申报中披露持有 RCUS(ARCUS BIOSCIENCES INC)675,516 股,市值约 US$17.4M,约占其申报组合的 1.57%,在其申报持仓中市值排名第 20 位。 Parkman Healthcare Partners LLC 最近 13 个申报季度中有 13 个季度披露了 RCUS 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Parkman Healthcare Partners LLC 对 RCUS 的持仓演变
Parkman Healthcare Partners LLC 于 Q3 2023 首次披露 RCUS 持仓:205,109 股(约 US$3.7M)。 该持仓在 Q2 2026 达到峰值 919,266 股,市值约 US$28.3M。 在 13 次申报中,Parkman Healthcare Partners LLC 8 次增持、4 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 675,516 股、市值约 US$17.4M,环比减持 -243,750 股。。 持仓曾出现大幅变动:Q2 2024 增持约 60% (随后一个季度股价基本持平)、Q3 2024 增持约 147% (随后一个季度股价下跌 3%)、Q2 2025 减持约 51% (随后一个季度股价上涨 67%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 205.11K | $3.68M | 新进 |
| Q4 2023 | 247.66K | $4.73M | 增持 |
| Q1 2024 | 259.92K | $4.91M | 增持 |
| Q2 2024 | 415.54K | $6.33M | 增持 |
| Q3 2024 | 1.03M | $15.68M | 增持 |
| Q4 2024 | 1.27M | $18.97M | 增持 |
| Q1 2025 | 1.22M | $9.54M | 减持 |
| Q2 2025 | 599.61K | $4.88M | 减持 |
| Q3 2025 | 652.68K | $8.88M | 增持 |
| Q4 2025 | 968.60K | $23.08M | 增持 |
| Q1 2026 | 1.21M | $26.08M | 增持 |
| Q2 2026 | 919.27K | $28.34M | 减持 |
| Q3 2026 | 675.52K | $17.45M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RCUS 与 13F 数据
RCUS(ARCUS BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 RCUS,申报仓位最大的包括:GILEAD SCIENCES, INC. (US$811.7M), MONTANOVA CAPITAL, LLC (US$147.3M), Siren, L.L.C. (US$62.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RCUS 的基金
- GILEAD SCIENCES, INC. 31.42M 股 · $811.70M · Q3 2026
- MONTANOVA CAPITAL, LLC 4.78M 股 · $147.26M · Q2 2026
- Siren, L.L.C. 2.42M 股 · $62.52M · Q3 2026
- Soleus Capital Management, L.P. 1.17M 股 · $36.03M · Q2 2026
- SAMLYN CAPITAL, LLC 1.39M 股 · $36.03M · Q3 2026
- BAKER BROS. ADVISORS LP 844.82K 股 · $26.05M · Q2 2026
- Sofinnova Investments, Inc. 626.18K 股 · $16.17M · Q3 2026
- Ikarian Capital, LLC 504.56K 股 · $15.56M · Q2 2026
- First Turn Management, LLC 577.69K 股 · $14.92M · Q3 2026
- DAFNA Capital Management LLC 441.83K 股 · $13.62M · Q2 2026
- Logos Global Management LP 500.00K 股 · $12.91M · Q3 2026
更多关于 Parkman Healthcare Partners LLC
常见问题
How long has Parkman Healthcare Partners LLC held RCUS?
Parkman Healthcare Partners LLC has disclosed RCUS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in RCUS?
As of Q3 2026, Parkman Healthcare Partners LLC holds 675.52K shares of RCUS (ARCUS BIOSCIENCES INC), valued at $17.45M, representing 1.57% of its reported portfolio and ranking #20.
Has Parkman Healthcare Partners LLC been buying or selling RCUS?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in RCUS. The position peaked in Q2 2026 at 919.27K shares.
Which other funds hold RCUS?
Other major institutional holders of RCUS include GILEAD SCIENCES, INC., MONTANOVA CAPITAL, LLC, Siren, L.L.C., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.